Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specialized in the application of deep learning for target identification, drug discovery, and aging research, announces the completion of a strategic round of funding led by WuXi AppTec’s Corporate Venture Fund. The strategic investment was conditional upon the successful experimental validation of Insilico Medicine’s Generative Adversarial Networks (GAN)…
GSK & Insilico to Research Use of Artificial Intelligence in Drug Discovery
Insilico establishes collaboration with GSK to discover novel biological targets and molecules. Insilico Medicine, a Baltimore-based company at the forefront of artificial intelligence (AI) research for drug discovery, biomarker development and aging research announced that it has formed a collaboration with GSK to explore how Insilico’s AI capability can enhance its drug discovery process. The…